Our findings of altered IL-4 signaling in patients with PD suggest that HPgV’s effects on cytokine regulation may depend on the host’s disease context and genetic background, highlighting the complex interplay between HPgV and immune pathways in different populations. The gene discussed is IL4; the disease is Parkinson disease.